JSPR Stock Price, Chart, Stats & News

Jasper Therapeutics, Inc.
Save
8.13M
Market cap
–
Current P/E
–
Forward P/E
JSPR chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -158.38% |
ROE | -261.95% |
D/E | 0.15x |
Interest coverage ratio | – |
JSPR valuation
P/E | – |
P/S | – |
P/B | 1.50x |
P/CF | -0.23x |
P/FCF | -0.22x |
P/OCF | -0.23x |
PEG | -0.10x |
EV multiple | -0.72x |
About
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing therapies for hematopoietic stem cell transplantation and gene therapies. Its core mission is to develop and commercialize conditioning agents and advanced stem cell engineering methods. These advancements aim to expand the utility of stem cell transplantation and ex vivo gene therapy, a process involving genetic modification of cells outside the body before their transplantation.
Similar securities
Based on sector and market capitalization
Report issue











